|
|
|
| Preparation of a novel iron-containing polymeric nanobubbles ultrsound contrast agents and its acoustic properties |
| LI Jiaping1, JIANG Yan1, WANG Doudou1, YU Fangfang2, CHENG Yueyue2, LIU Zhe1 |
| 1.School of Ophthalmology & Optometry, School of Biomedical Engineering, Wenzhou Medical University, Wenzhou 325027, China; 2.Department of Ultrasonic Imaging, the Second Affiliated Hospital & Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou 325027, China |
|
| Cite this article: |
|
LI Jiaping,JIANG Yan,WANG Doudou, et al. Preparation of a novel iron-containing polymeric nanobubbles ultrsound contrast agents and its acoustic properties[J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2019, 49(4): 249-252，257.
|
|
|
|
Abstract Objective: To prepare iron-containing polybutyl cyanoacrylate (PBCA) hybrid nanobubbles (UPNBs) and to explore the properties and ultrasonic imaging intensity of hybrid nanobubbles under different conditions. Methods: The nanobubbles (NBs) were produced via emulsion polymerization of PBCA and were purified by a simple mechanical agitation, and the UPNBs were prepared via an oil-in-water (O/W) encapsulation of iron oxide nanoparticles in the bubble shell. The mean diameter and concentration of UPNBs were analyzed by using a Beckmann Coulter Counter. The iron concentration in different UPNBs batches was determined by inductively coupled plasma mass spectrometer (ICP-MS). Furthermore, the contrast of UPNBs in ultrasound (US) imaging was evaluated by an ultrasound scanner. Results: These polymeric NBs exhibited strong contrast in US imaging. Moreover, with the iron concentration increasing, the size of UPNBs changed slightly and they had excellent backscattering capability in US imaging. Conclusion: These nanobubbles are candidates as hybrid imaging agents for US molecular imaging, which may be potential vehicles for MRI-guided US-mediated drug and gene delivery.
|
|
Received: 25 November 2018
|
| |
|
|
|
[1] GAUR U, SAHOO S K, DE T K, et al. Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system[J]. Int J Pharm, 2000, 202(1-2): 1-10.
[2] OEFFINGER B E, WHEATLEY M A. Development and characterization of a nano-scale contrast agent[J]. Ultrasonics, 2004, 42(1-9): 343-347.
[3] DAI J, ZOU S, PEI Y, et al. Polyethylenimine-grafted copolymer of poly(l-lysine) and poly (ethylene glycol) for gene delivery[J]. Biomaterials, 2011, 32(6): 1694-1705.
[4] JOLESZ F A. MRI-guided focused ultrasound surgery[J]. Annu Rev Med, 2009, 60: 417-430.
[5] CAVALLI R, BISAZZA A, TROTTA M, et al. New chitosan nanobubbles for ultrasound-mediated gene delivery: preparation and in vitro characterization[J]. Int J Nanomedicine, 2012, 7: 3309-3318.
[6] WANG Y, LI X, ZHOU Y, et al. Preparation of nanobubbles for ultrasound imaging and intracelluar drug delivery[J]. Int J Pharm, 2010, 384(1-2): 148-153.
[7] PALMOWSKI M, HUPPERT J, LADEWIG G, et al. Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effects[J]. Mol Cancer Ther, 2008, 7(1): 101-109.
[8] VAN EETEN K M P, HOUBEN H H H, VAN DERSCHAAF J, et al. An experimental and theoretical study on the size of bubbles formed between a rotating disc and a stationary wall[J]. Chem Eng Sci, 2014, 109(3): 251-263.
[9] CAVALLI R, SOSTER M, ARGENZIANO M. Nanobubbles: a promising efficient tool for therapeutic delivery[J]. Ther Deliv, 2016, 7(2): 117-138.
[10] MARXER E E, BRÜSSLER J, BECKER A, et al. Development and characterization of new nanoscaled ultrasound active lipid dispersions as contrast agents[J]. Eur J Pharm Biopharm, 2011, 77(3): 430-437.
[11] YANG H, CAI W, XU L, et al. Nanobubble-Affibody: Novel ultrasound contrast agents for targeted molecular ultrasound imaging of tumor[J]. Biomaterials, 2015, 37: 279-288.
[12] MILLER D L, AVERKIOU M A, BRAYMAN A A, et al. Bioeffects considerations for diagnostic ultrasound contrast agents[J]. J Ultrasound Med, 2008, 27(4): 611-632.
[13] KAUL S. Myocardial contrast echocardiography: a 25-year retrospective[J]. Circulation, 2008, 118(3): 291-308.
[14] RAFAILIDIS V, FANG C, YUSUF G T, et al. Contrast-enhanced ultrasound (CEUS) of the abdominal vasculature[J]. Abdom Radiol (NY), 2018, 43(4): 934-947.
[15] HUANG H Y, HU S H, HUNG S Y, et al. SPIO nanoparticle-stabilized PAA-F127 thermosensitive nanobubbles with MR/US dual-modality imaging and HIFU-triggered drug release for magnetically guided in vivo tumor therapy[J]. J Control Release, 2013, 172(1): 118-127.
[16] LIU Z, LAMMERS T, EHLING J, et al. Iron oxide nanoparticle-containing microbubble composites as contrast agents for MR and ultrasound dual-modality imaging[J]. Biomaterials, 2011, 32(26): 6155-6163.
[17] SONG S, GUO H, JIANG Z, et al. Self-assembled microbubbles as contrast agents for ultrasound/magnetic resonance dual-modality imaging[J]. Acta Biomater, 2015, 24: 266-278.
[18] AO M, WANG Z, RAN H, et al. Gd-DTPA-loaded PLGA microbubbles as both ultrasound contrast agent and MRI contrast agent-a feasibility research[J]. J Biomed Mater Res B Appl Biomater, 2010, 93(2): 551-556.
[19] WU H, ROGNIN N G, KRUPKA T M, et al. Acoustic characterization and pharmacokinetic analyses of new nanobubble ultrasound contrast agents[J]. Ultrasound Med Biol, 2013, 39(11): 2137-2146. |
|
|
|
